NEW YORK, Sept. 25 - Orchid BioSciences has entered into a commercial SNP genotyping partnership with the Oklahoma Medical Research Foundation to study autoimmune diseases, especially lupus, the company said on Tuesday.

Terms of the deal call for Orchid to use its MegaSNPatron facility for an undisclosed fee to perform high throughput SNP scoring on samples provided by OMRF.

Further details of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.